Business · 26/05/2004

FDA Releases Guidance on Handling and Retention of Bioavailability and Bioequivalence Testing Samples

The Food and Drug Administration (FDA) has made available a guidance document for industry, outlining procedures for handling reserve samples from bioavailability and bioequivalence studies, aimed at ensuring the integrity of testing samples for pharmaceutical companies and researchers.